These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 36268270)
1. Efficacy and safety comparison of Wang Z; Wang F Therap Adv Gastroenterol; 2022; 15():17562848221125308. PubMed ID: 36268270 [TBL] [Abstract][Full Text] [Related]
2. Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion? Dong SQ; Singh TP; Wei X; Yao H; Wang HL Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28884937 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis. Zhang WL; Lin BS; Li YY; Ding YM; Han ZX; Ji R Digestion; 2023; 104(4):249-261. PubMed ID: 37015201 [TBL] [Abstract][Full Text] [Related]
4. Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori. Furuta T; Yamade M; Kagami T; Uotani T; Suzuki T; Higuchi T; Tani S; Hamaya Y; Iwaizumi M; Miyajima H; Umemura K; Osawa S; Sugimoto K Digestion; 2020; 101(6):743-751. PubMed ID: 31434101 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials. Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003 [TBL] [Abstract][Full Text] [Related]
6. Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Sue S; Suzuki Y; Sasaki T; Kaneko H; Irie K; Komatsu K; Maeda S J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685510 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of vonoprazan combined with different dose amoxicillin on eradication of Lin Y; Xu H; Yun J; Yu X; Shi Y; Zhang D Ann Transl Med; 2022 Sep; 10(18):987. PubMed ID: 36267745 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. Kajihara Y; Shimoyama T; Mizuki I Scand J Gastroenterol; 2017 Feb; 52(2):238-241. PubMed ID: 27806639 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)-based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials. Sun Y; Yue L; Hu W Eur J Clin Pharmacol; 2023 Feb; 79(2):279-288. PubMed ID: 36527456 [TBL] [Abstract][Full Text] [Related]
10. Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori. Saito Y; Konno K; Sato M; Nakano M; Kato Y; Saito H; Serizawa H Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669474 [TBL] [Abstract][Full Text] [Related]
11. Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Mori N; Nishiura Y; Suga D; Moritani I; Yamanaka Y; Ooya Y; Inoue H; Takase K; Hioki M; Shiraki K Biomed Rep; 2018 Aug; 9(2):169-174. PubMed ID: 30013779 [TBL] [Abstract][Full Text] [Related]
12. Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility. Okubo H; Akiyama J; Kobayakawa M; Kawazoe M; Mishima S; Takasaki Y; Nagata N; Shimada T; Yokoi C; Komori S; Kimura K; Hisada Y; Iwata E; Watanabe K; Yanagisawa N; Shiroma S; Shimomura A; Okahara K; Cho H; Uemura N J Gastroenterol; 2020 Nov; 55(11):1054-1061. PubMed ID: 32930864 [TBL] [Abstract][Full Text] [Related]
13. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Suzuki S; Gotoda T; Kusano C; Ikehara H; Ichijima R; Ohyauchi M; Ito H; Kawamura M; Ogata Y; Ohtaka M; Nakahara M; Kawabe K Gut; 2020 Jun; 69(6):1019-1026. PubMed ID: 31915235 [TBL] [Abstract][Full Text] [Related]
14. A Triple-Drug Blister-Packaged Drug with Vonoprazan Improves First-Line Eradication of Helicobacter pylori in Elderly Patients: A Retrospective Propensity Score-Matched Cohort Study. Nishida T; Tsujii Y; Okamoto A; Tomita R; Higaki Y; Osugi N; Sugimoto A; Takahashi K; Mukai K; Nakamatsu D; Matsubara T; Hayashi S; Yamamoto M; Nakajima S; Fukui K; Inada M Digestion; 2020; 101(5):608-614. PubMed ID: 31288235 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis. Shinozaki S; Kobayashi Y; Osawa H; Sakamoto H; Hayashi Y; Lefor AK; Yamamoto H Digestion; 2021; 102(3):319-325. PubMed ID: 31914442 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Zhang Z; Liu F; Ai F; Chen X; Liu R; Zhang C; Fang N; Fu T; Wang X; Tang A Front Pharmacol; 2023; 14():1143969. PubMed ID: 37214450 [No Abstract] [Full Text] [Related]
17. Single-Arm, Prospective, Interventional Study of Sue S; Ikeda R; Ikeda A; Sato H; Kaneko H; Irie K; Maeda S J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999340 [No Abstract] [Full Text] [Related]
18. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. Jung YS; Kim EH; Park CH Aliment Pharmacol Ther; 2017 Jul; 46(2):106-114. PubMed ID: 28497487 [TBL] [Abstract][Full Text] [Related]
20. Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Maruyama M; Tanaka N; Kubota D; Miyajima M; Kimura T; Tokutake K; Imai R; Fujisawa T; Mori H; Matsuda Y; Wada S; Horiuchi A; Kiyosawa K Can J Gastroenterol Hepatol; 2017; 2017():4385161. PubMed ID: 28349044 [No Abstract] [Full Text] [Related] [Next] [New Search]